Cerecor Inc. (NASDAQ:CERC) posted its earnings results on Monday. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.29) by $0.15, MarketWatch Earnings reports. Cerecor had a negative net margin of 864.87% and a negative return on equity of 896.66%. The firm had revenue of $0.16 million during the quarter.

Shares of Cerecor (NASDAQ CERC) opened at 0.5852 on Tuesday. The company’s market cap is $8.24 million. The stock has a 50 day moving average of $0.72 and a 200 day moving average of $0.68. Cerecor has a 1-year low of $0.34 and a 1-year high of $5.60.

In related news, Director Armistice Capital Master Fund purchased 72,672 shares of the stock in a transaction dated Friday, May 19th. The stock was purchased at an average price of $0.63 per share, with a total value of $45,783.36. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 10.70% of the stock is owned by insiders.

COPYRIGHT VIOLATION WARNING: This report was originally published by Watch List News and is the property of of Watch List News. If you are viewing this report on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this report can be viewed at https://www.watchlistnews.com/cerecor-inc-cerc-posts-quarterly-earnings-results-beats-expectations-by-0-15-eps/1490114.html.

Cerecor Company Profile

Cerecor, Inc is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive treatment for major depressive disorder (MDD); CERC-501, which is for substance use disorders and adjunctive treatment of MDD, and CERC-406, which is for the treatment of cognitive impairment.

Earnings History for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.